Page last updated: 2024-09-03

arg-3-hyp-7-phe-bradykinin and 4-diphenylacetoxy-n-methylpiperidine methiodide

arg-3-hyp-7-phe-bradykinin has been researched along with 4-diphenylacetoxy-n-methylpiperidine methiodide in 4 studies

Compound Research Comparison

Studies
(arg-3-hyp-7-phe-bradykinin)
Trials
(arg-3-hyp-7-phe-bradykinin)
Recent Studies (post-2010)
(arg-3-hyp-7-phe-bradykinin)
Studies
(4-diphenylacetoxy-n-methylpiperidine methiodide)
Trials
(4-diphenylacetoxy-n-methylpiperidine methiodide)
Recent Studies (post-2010) (4-diphenylacetoxy-n-methylpiperidine methiodide)
522327010

Protein Interaction Comparison

ProteinTaxonomyarg-3-hyp-7-phe-bradykinin (IC50)4-diphenylacetoxy-n-methylpiperidine methiodide (IC50)
Muscarinic acetylcholine receptor M2Homo sapiens (human)0.055
Muscarinic acetylcholine receptor M4Homo sapiens (human)0.0009
Muscarinic acetylcholine receptor M5Homo sapiens (human)0.0005
Muscarinic acetylcholine receptor M1Homo sapiens (human)0.0045
Muscarinic acetylcholine receptor M3Homo sapiens (human)0.0014

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X1
Belyakov, S; Dambrova, M; Kazoka, H; Kuznecovs, J; Lebedev, A; Liepinsh, E; Mishnev, A; Orlova, N; Ponomaryov, Y; Vavers, E; Veinberg, G; Vikainis, S; Vilskersts, R; Vorona, M; Zvejniece, L1
Bednarski, M; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pękala, E; Powroźnik, B; Słoczyńska, K; Walczak, M; Waszkielewicz, AM; Żesławska, E1
Filipek, B; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pańczyk, K; Pękala, E; Rapacz, A; Słoczyńska, K; Waszkielewicz, AM; Żelaszczyk, D; Żesławska, E1

Other Studies

4 other study(ies) available for arg-3-hyp-7-phe-bradykinin and 4-diphenylacetoxy-n-methylpiperidine methiodide

ArticleYear
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
    Journal of medicinal chemistry, 2008, Jul-24, Volume: 51, Issue:14

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship

2008
Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.
    Bioorganic & medicinal chemistry, 2013, May-15, Volume: 21, Issue:10

    Topics: Acetamides; Allosteric Regulation; Animals; Rats; Rats, Wistar; Receptors, sigma; Sigma-1 Receptor; Stereoisomerism; Structure-Activity Relationship

2013
Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.
    Bioorganic & medicinal chemistry, 2016, Apr-15, Volume: 24, Issue:8

    Topics: Amino Alcohols; Animals; Anticonvulsants; Chemistry, Physical; Dose-Response Relationship, Drug; Drug Design; Epilepsy; Male; Mice; Microsomes, Liver; Molecular Structure; Pilocarpine

2016
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH
    Bioorganic & medicinal chemistry, 2017, 01-15, Volume: 25, Issue:2

    Topics: Amino Alcohols; Animals; Anticonvulsants; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Mice; Models, Molecular; Molecular Structure; Rats; Seizures; Structure-Activity Relationship

2017